Extensive R&D Capabilities:ICP DAS - BMP to Showcase a Broad Range of Medical-Grade TPU at MD&M West 2024, U.S.

January 23, 2024 01:06 PM AEDT | By Cision
 Extensive R&D Capabilities:ICP DAS - BMP to Showcase a Broad Range of Medical-Grade TPU at MD&M West 2024, U.S.
Image source: Kalkine Media

HSINCHU, Jan. 23, 2024 /PRNewswire/ -- ICP DAS – BMP, Asia's first medical-grade thermoplastic polyurethane (TPU) supplier, will make its MD&M West debut in the United States. Kicking off 2024, the company presents a comprehensive range of top-quality medical-grade TPU series to the foremost experts and a thousand suppliers in the medical industry.

Extensive R&D Capabilities:ICP DAS – BMP to Showcase a Full Range of Medical-Grade TPU at MD&M West 2024, U.S.
Extensive R&D Capabilities:ICP DAS – BMP to Showcase a Full Range of Medical-Grade TPU at MD&M West 2024, U.S.

Exhibits include Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series) products. Each TPU series is offered in varying hardness and loading percentages of radiopaque fillers (Tungsten/Barium Sulfate), allowing customers to select the perfect fit to manufacture various medical devices.

Medical imaging devices are essential for medical treatments. Using in situ polymerization, the expert team has formulated TPU pellets containing 20% and 40% Barium Sulfate for all series. Additionally, ALC series featuring 30% Barium Sulfate is also available.

Furthermore, the team has introduced ARP-W and ALP-W series loaded with 30-80% Tungsten catering for small-dimension or thin-walled device production. Tungsten-filled TPU products deliver exceptional imaging, making them optimal options for manufacturing minimally invasive medical devices.

Next, ICP DAS – BMP will launch EARP and EALP series exhibiting high hardness, excellent heat resistance, and superior processability. The company also prioritizes "Quality Management" for each TPU batch by performing rigorous quality inspection and processing testing, and implements smart factory solutions with continuous improvement to ensure "Short Delivery Times."

Medical device manufacturers worldwide have adopted ICP DAS – BMP's TPU products after thorough evaluation and testing. Providing strong after-sales support and options for small order quantities specifically for early stages of product development, ICP DAS – BMP ramps up business development globally and creates a win-win situation for clients and the company.

@MD&M West 2024, explore more with ICP DAS – BMP at booth 947 (Hall E) in the Anaheim Convention Center from February 6 to 8.

About ICP DAS – BMP
ICP DAS – BMP, an ISO 13485-certified TPU manufacturer and supplier in Taiwan, owns dedicated laboratories and offers USP Class VI and/or ISO 10993 certified TPU series: ISO 10993-4 for hemocompatibility testing, ISO 10993-5 for cytotoxicity testing, ISO 10993-6 for local effects after implantation, ISO 10993-10 for skin sensitization testing, ISO 10993-11 for systemic toxicity testing, and ISO 10993-23 for irritation testing. The products also comply with REACH and RoHS.

For further information:https://bmp.icpdas.com/

For TPU products and inquiries: [email protected] 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.